These findings of p53 regulation by LIN28B provide insights into how cancer cells can impede the function of a key tumor suppressor in the absence of gene mutation, and potentiate the application of LIN28B as a stratification biomarker to p53–MDM2 PPI therapy. Here, MDM2 is linked to cancer.